"Artrozan": kauoha no ka hoʻohana

"Artrozan" kauoha no ka hoʻohana pili ia i ka lapaʻau a me ka pharmacological waeʻano o oxicams. I ka papa kuhikuhiEʻeleu waiwai o ka la hoomalolo - meloxicam i mea mana e wae Punk-2 inhibitor. Me ke kuleana "Meloxicam" keia k ua kakau ia ma ka? Aaeno? O hale hookipa.

I ka papa palapala o ka lāʻau ua i loko o na papa he 15 mg a 7,5 piha i blisters metering contour.

Ma pharmacological waiwai lapaau "meloxicam", ua loko mai enolievoyʻakika waiwai, he mea o Anati-hoʻoʻino a me ka analgesic hana. Kēiaʻano papa hana ua ma muli o ka hiki mai o ka lāʻau, e inhibit i ke kaʻina hana o ka synthesizing prostaglandins. Ma lalo o ka aoao o ka lāʻau naoh i, i ka wā i selectively inhibit i ka ha awina o Punk-2 nā'ūhū, i komo 'ana i loko o ka papa kuhikuhiE biosynthesis.

Oiai lawe i ka lāʻau, "Artrozan" alakai wehewehe kona hana ana ma keia ala. Inā ka lapaau e lawelawe i loko o nā māhele kiʻekiʻe, laila, i loko o ka wā lōʻihi o ko lākou hoʻohana mea he emi ma ka selectivity no Punk-2. Ka lapaau emi e loli ai Punk-1, a malama i ka gastrointestinal'āpana. ʻO ia manawa a hiki i kēia e wae 'ana, a hoomalu i ka gastrointestinal'āpana, mai ka erosive a me ka ulcerative lesions.

Ke Anati-hoʻoʻino lāʻau kanawai "Artrozan" manual hoʻohuiʻia me ka suppression o ka'ūhū ha awina o Punk-2, i hana i loko o ka papa o ka hoʻoʻino kaʻina.

Pharmacokinetics "Meloxicam" Ua wehewehe aku penei. Hoi o ka makana "Artrozan" hiki i ka lanakila i ke kino-'aʻaʻa o ke'ākeʻakeʻa mai, ma muli o ia keia hui me ka wai koko nā polokina like kiʻekiʻe me 99%. I ka haku mele 'ana o synovial loli lehulehu cia ma keia hihia, he 50%.

Pūnao: ka lāʻau kokoke loa metabolized i ake keena, pela ka mea, i ke kahua o kekahi mau pharmacologically'ākilikai nā mea loaʻa.

Excretion: Ka huahana "meloxicam" hōʻike e pili ana i kau like maheleʻano nui i loko o ka mimi a me feces i loko o ka palapala o metabolic huahana. Wale nō 5% o ka eiiiiiaiou mea auoiaea mai o ka naʻau liʻiliʻi.

Ke pharmacokinetic waiwai o ka lāʻau "Artrozan" manual kekahi hoʻoholo no ka kūikawā hihia. Ma kekahi,ʻelemākule e hoʻomanawanui iki mai ka wā o ka loaa ana hoemiʻae o ka lāʻau, a ma ka hihia o symptoms o hepatic a me kaʻaʻa puʻuwai 'ole, i ka lāʻau mea immaterial ia ma luna o nā pharmacokinetics.

E hoomakaukau ai "meloxicam" ua hala loa pono ke kemu, mai ka gastrointestinal'āpana, i ke bioavailability o kona 'ilikai kīnā 89% a me ka ua ole loli ana i ka aiʻai ana. ? Eaia ma nā māhele he mahele lāʻau hoʻolako hapaʻauhau lehulehu o ka lāʻau i loko o ke kino.

Haawi aku: IeAUPIIe, IAa IO, e pono ai ke hana CSS ana ma luna o ke kolu a hiki i ka lāʻalima o ka lapaʻau, oiai kona lōʻihi-makahiki hoʻohana i hoomakaukau i ka pilina paʻa nā hoʻohui like like me ka loiloi mua pharmacokinetic kiko'î.

Ke laʻau heluna o ka lāʻau "Artrozan 'kauoha no ka hoʻohana ua nānā' ia penei.

Pili i ka lāʻau ma ka hui palapala ua paipai. Ke paipai regimen:

- ma ka loiloi mua kahua o ka lapaʻau, no ka 2-3 lā, noi "Artrozan" -ukoly;

- ma hope ekolu, eha paha lā o ka intramuscular hooponopono e neʻe e loaa una ka lapaʻauʻia - i loko o ka palapala o ka papa.

Ka laʻau heluna no ka intramuscular hoʻoponopono, a no ka moʻolelo hooponopono i ka ia, a me ka ewaewa ole i ka hae (7.5 a 15 mg) koke kela la i keia no ka lā. Ka mahele lāʻau a me ka lōʻihi like 'ole o ka palapala noi nānā' ana i ka nui o kaʻeha a me ka degere o ka oolea o ka li nui. Ma ka hoomaopopo ana i ka mahele lāʻau e e pono ia i loko o ka mooolelo o ka Loaʻaʻia kamepiula o complications mai ka gastrointestinal'āpana.

Ma ke alo o kaʻaʻa puʻuwai ole, ka mea i kela la i kā mākou mahele lāʻau o ka ole oi aku 7,5 mg.

Hana kūleʻa me nā ai 'i ke huikau ma ka hanana o ke erosive-ulcerous' ole i loko o ka gastrointestinal'āpana. Mai lawe i ka lāʻau i hāpai keiki, a breastfeeding.

Product "Meloxicam" pono e malamaia ma ka pouli wahi no ka oi ma mua o nā makahiki i.

Uluwehi O kūʻaiʻia ma kuhikuhi wale.